| Study | Sample Size | Tumor Type | Duration of Follow-Up | Number (%) with Neovascular Glaucoma at End of Follow-Up | Predictors of Neovascular Glaucoma after Treatment |
| Sagoo et al. 2007 [10] | 37 patients | Circumpapillary choroidal melanoma | Mean 52 months, median 46 months | 5/37 (13.5%) | -- |
| Sagoo et al. 2008 [11] | 141 patients | Juxtapapillary choroidal melanoma overhanging optic disc | Mean 56 months | 24/141 (17.0%) | -- |
| Finger et al. 2012 [16] | 24 patients | Choroidal melanomas within 1.5 mm of optic disc treated with slotted radiotherapy | Mean 23 months | 0/24 (0.0%) | -- |
| Krema et al. 2013 [38] | 30 patients | Posterior tumor margin 0 - 2.5 mm from optic disc |
| 8% | -- |
| Marconi et al. 2013 [31] | 94 patients | Choroidal melanoma treated with ruthenium brachytherapy | Median 39 months | 3% with secondary glaucoma | -- |
| Sagoo et al. 2014 [32] | 650 eyes | Juxtapapillary choroidal melanoma | Median 40 months | 15% at 5 years | Mean tumor thickness |
| Semenova et al. 2014 [20] | 47 patients | T3 or T4 sized choroidal melanomas treated with palladium brachytherapy | Median 47 months | 8/47 (17%) with secondary glaucoma | -- |